Ferronemia is intended to provide a solution for Iron deficiency and Iron deficiency anemia in Chronic Kidney Disease Patients by increasing the systemic Iron level and hemoglobin level with its unique mechanism of action. Ferronemia is patented in several countries including India, Canada, Europe & Australia.
Obepparalpha is a breakthrough and novel solution launched in India. It is a unique and Patented product indicated for BMI and Obesity management.
A pioneering product in India, Neuronomic is a unique Patent Applied product indicated for management of Neurodegenerative disease which occurs due to disturbances in Iron homeostasis. The product has been manufactured in Technical Collaboration with a USA Based Research Company, Enavant Research.
FERRONOMIC is intended to provide a solution for the Iron deficiency and Iron deficiency anemia in pregnant women by increasing the systemic
Iron level and hemoglobin level with its unique mechanism of action.
CELIZAREN, a blend of JYUNKA has been manufactured in accordance with MPFAITECH intended to provide a solution for the chronic inflammation in CKD which as per various scientific evidences is thought to be one of the major factors responsible for the onset and progression of CKD. CELIZAREN is patented in several countries including India, USA, Canada & Europe (BE, FR, DE, IE, LI, LU, MC, CH & GB).
PALMIGES contains the proprietary blend RITALA and has been manufactured in technical collaboration with a USA Based Research Consultancy – ENAVANT RESEARCH LLC. The product PALMIGES utilizes the Trademarked Technology of MPFAITECH to help provide a solution to the problem of Neuropathic Pain by controlling the excessive inflammation which, may not only be responsible for the initiation but also the maintenance of persistent pain.
